Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-009525

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alan J Main
Officer — EVP, CMC and Supply Operations
Period of report
Mar 2, 2015
Accepted (ET)
Mar 3, 2015 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 2, 2015M16,250—A162,600D
Common StockF1Mar 2, 2015M17,500—A180,100D
Common StockF1Mar 2, 2015M16,500—A196,600D
Common StockF1Mar 2, 2015M18,750—A215,350D
Common StockMar 2, 2015F25,318$0.94D190,032D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Mar 2, 2015M16,250D——Common Stock16,2500D
Restricted Stock Units (Phantom Stock)F1,F4—Mar 2, 2015M17,500D——Common Stock17,50017,500D
Restricted Stock Units (Phantom Stock)F1,F5—Mar 2, 2015M16,500D——Common Stock16,50033,000D
Restricted Stock Units (Phantom Stock)F1,F6—Mar 2, 2015M18,750D——Common Stock18,75056,250D

Explanation of responses